Hans Preusting

Hans Preusting is the founder of Synerkine Pharma BV.
He currently holds the position of Director at Oxyrane UK Ltd. and Independent Director at Mendus AB. He is also a Member-Supervisory Board at PharmaCell BV and DCPrime BV.
Previously, he served as Director-Influenza & Cell Culture Vaccine at Abbott Healthcare Products BV from 2003 to 2006.
From 2006 to 2013, he was the Director-Operations & Business Development at Amsterdam Molecular Therapeutics (AMT) Holding NV.
He also worked as the Manager-Operations at DSM Biologics Holding, Inc. from 1999 to 2003.
Additionally, he held the positions of Chief Operating & Business Officer at uniQure NV and Chief Development Officer at DegenRx BV.
Dr. Preusting obtained an MBA and a doctorate from Rotterdam School of Management.
He also holds a doctorate from the University of Groningen.